Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease

JAMA. 2002 Jan 9;287(2):190; author reply 191-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Coronary Artery Disease / economics
  • Coronary Artery Disease / prevention & control*
  • Cost-Benefit Analysis
  • Dietary Supplements* / economics
  • Folic Acid / therapeutic use
  • Homocysteine / blood
  • Humans
  • Vitamins / therapeutic use*

Substances

  • Vitamins
  • Homocysteine
  • Folic Acid